Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder / Ole Köhler-Forsberg en The British Journal of Psychiatry, Año 2019 - Vol. 215 - No. 2 (Agosto)

Público ISBD [artículo]  inThe British Journal of Psychiatry > Año 2019 - Vol. 215 - No. 2 (Agosto) . - pp. 494-501 Título : Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder Tipo de documento: texto impreso Autores: Ole Köhler-Forsberg, Autor ; Erik Roj Larsen, Autor ; Henriette N. Buttenschøn, Autor Fecha de publicación: 2019 Artículo en la página: pp. 494-501 Idioma : Inglés (eng) Palabras clave: Depresión, No respondedores, Efectos secundarios, Antidepresivos, Traspuesta Resumen: For patients with major depressive disorder (MDD) experiencing side-effects or non-response to their first antidepressant, little is known regarding the effect of switching between a tricyclic antidepressant (TCA) and a selective serotonin reuptake inhibitor (SSRI). Link: ./index.php?lvl=notice_display&id=21013 [artículo] Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder [texto impreso] / Ole Köhler-Forsberg, Autor ; Erik Roj Larsen, Autor ; Henriette N. Buttenschøn, Autor . - 2019 . - pp. 494-501. Idioma : Inglés (eng) in The British Journal of Psychiatry > Año 2019 - Vol. 215 - No. 2 (Agosto) . - pp. 494-501 Palabras clave: Depresión, No respondedores, Efectos secundarios, Antidepresivos, Traspuesta Resumen: For patients with major depressive disorder (MDD) experiencing side-effects or non-response to their first antidepressant, little is known regarding the effect of switching between a tricyclic antidepressant (TCA) and a selective serotonin reuptake inhibitor (SSRI). Link: ./index.php?lvl=notice_display&id=21013

---

1 (1 - 1 / 1)